Homestead Advisers’s Twist Bioscience TWST Stock Holding History

Homestead Advisers’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61,977	Closed	-$1.26M	–	136
2023 Q3	$1.26M	Hold	61,977	–	–	0.03%	97
2023 Q2	$1.27M	Hold	61,977	–	–	0.03%	97
2023 Q1	$935K	Hold	61,977	–	–	0.03%	100
2022 Q4	$1.48M	Hold	61,977	–	–	0.04%	99
2022 Q3	$2.18M	Hold	61,977	–	–	0.07%	92
2022 Q2	$2.17M	Buy	61,977 +15,000	+32%	+$531K	0.06%	97
2022 Q1	$2.32M	Hold	46,977	–	–	0.06%	101
2021 Q4	$3.64M	Hold	46,977	–	–	0.08%	85
2021 Q3	$5.03M	Buy	46,977 +1,200	+3%	+$137K	0.12%	73
2021 Q2	$6.1M	Buy	45,777 +3,300	+8%	+$384K	0.14%	71
2021 Q1	$5.26M	Sell	42,477 -29,400	-41%	-$4.46M	0.13%	74
2020 Q4	$10.2M	Sell	71,877 -32,700	-31%	-$3.63M	0.25%	51
2020 Q3	$7.95M	Hold	104,577	–	–	0.22%	57
2020 Q2	$4.74M	Sell	104,577 -1,100	-1%	-$39.5K	0.12%	68
2020 Q1	$3.23M	Buy	+105,677	New	+$2.84M	0.1%	78

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Homestead Advisers's TWST Position: Q4 2023 in Review

Homestead Advisers sold out of Twist Bioscience (TWST) in Q4 2023, closing a stake of 61,977 shares — an estimated $1.26M sold.

Homestead Advisers first reported a position in TWST in Q1 2020 and held it in 15 quarters. The position peaked at $10.2M in Q4 2020. 219 funds tracked by Wall St. Rank hold TWST as of Q4 2023.

Homestead Advisers reported no remaining Twist Bioscience position as of Q4 2023 after selling out during the quarter.
Homestead Advisers sold 61,977 Twist Bioscience shares in Q4 2023, an estimated $1.26M.
Homestead Advisers first reported a position in Twist Bioscience in Q1 2020 and held it in 15 quarters.
Homestead Advisers's Twist Bioscience position peaked at $10.2M in Q4 2020.
219 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2023.

Based on Homestead Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.